Timing and dosage may be the key in the realisation of hydroxychloroquine + azithromycin treatment benefit in Covid-19 elderly patients

Detalles Bibliográficos
Autores principales: Lacout, Alexis, Lounnas, Valere, Perronne, Christian
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier Ltd and International Society of Antimicrobial Chemotherapy. 2021
Materias:
Letter to the Editor
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7967398/
https://www.ncbi.nlm.nih.gov/pubmed/33722657
http://dx.doi.org/10.1016/j.ijantimicag.2021.106314

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7967398/
https://www.ncbi.nlm.nih.gov/pubmed/33722657
http://dx.doi.org/10.1016/j.ijantimicag.2021.106314

Ejemplares similares